Back to
Driehaus Capital Management LLC
CRNX
26 quarters
Position history for
Driehaus Capital Management LLC's holdings in CRINETICS PHARMACEUTICALS INC
As of its Q2 2026 13F, Driehaus Capital Management held 6,463,551 shares of CRNX (Crinetics Pharmaceuticals), worth $241.9M. Driehaus Capital Management's 13F filings listed CRNX from Q2 2020 to Q2 2026, 25 quarterly filings. CRNX was 1.4% of Driehaus Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$15.5M
Total Shares Change
-886,762
Quarter-by-Quarter History